This article is a correction to:
CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
Chenhui Cai1
Tongwei Chu- 1Department of Orthopedics, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China
- 2Department of Biomedical Materials Science, Third Military Medical University (Army Medical University), Chongqing, China
A Corrigendum on:
CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
By Cai C, Zhang Y, Hu X, Hu W, Yang S, Qiu H, Chu T. Front Oncol. 11:721644. doi: 10.3389/fonc.2021.721644
In the original article, there was a mistake in Figure 11 as published. In Figures 11D, E, we put the wrong pictures of wound healing assay in NC group at 0 h of both conditions. We made a mistake when we dragged the original figure into the AI software. We re-examined the original experiment notes and confirmed that this omission did not affect the statistical results and conclusions. The corrected Figure 11 appears below.
FIGURE 11
Figure 11 Silencing of CDT1 inhibited the proliferation, migration and invasion of HCC cells. (A) Western blot detection of CDT1 expression after knockdown of CDT1 in liver cancer cells. (B) The effect of CDT1 knockdown on cell viability at 24, 48, 72 and 96h after seeding in plates was measured by CCK-8 assay. (C–E) Transwell analysis and wound healing assay reflected the migration ability of LM3 and Hep3B cell lines. (F) Images of the colony formation assay after knockdown of CDT1 in HCC cells (G, H) Relative quantification of the colony areas is shown. Scale bars in (F) equal 5mm. Data are expressed as means ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: CDT1, liver hepatocellular carcinoma, prognostic value, immune infiltration, bioinformatics analysis
Citation: Cai C, Zhang Y, Hu X, Hu W, Yang S, Qiu H and Chu T (2021) Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma. Front. Oncol. 11:801970. doi: 10.3389/fonc.2021.801970
Received: 26 October 2021; Accepted: 28 October 2021;
Published: 09 November 2021.
Edited and reviewed by:
Peti Thuwajit, Mahidol University, ThailandCopyright © 2021 Cai, Zhang, Hu, Hu, Yang, Qiu and Chu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tongwei Chu, chtw@sina.com